Literature DB >> 23370271

Grail as a molecular determinant for the functions of the tumor suppressor p53 in tumorigenesis.

Y-C Chen1, J Y-H Chan, Y-L Chiu, S-T Liu, G Lozano, S-L Wang, C-L Ho, S-M Huang.   

Abstract

The transcription factor p53 is a multifunctional tumor suppressor that arrests the cell cycle in response to stress and modulates the DNA repair process or induces apoptosis. The cellular level and activity of p53 are tightly controlled to maintain proper functioning. This study identified a novel p53-binding glycoprotein, gene related to anergy in lymphocytes (Grail), which formed a negative feedback loop (similar to that of Mdm2). Grail physically and functionally interacted with the N-terminus of p53 to target its degradation and modulate its transactivation activity. Grail also senses and regulates cellular p53 levels, modulates a panel of p53-targeted promoters, and has a role in p53-induced apoptosis in cultured cells. Overexpression of Grail inhibited p53-induced apoptosis by increasing p53 degradation. However, cells not expressing Grail failed to undergo p53-dependent apoptosis, resulting in p21-dependent G1 arrest. Thus, Grail may provide a novel regulatory route for controlling p53 activity under stress conditions.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23370271      PMCID: PMC3619241          DOI: 10.1038/cdd.2013.1

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


  31 in total

1.  cDNA library screening using the SOS recruitment system.

Authors:  W Huang; S L Wang; G Lozano; B de Crombrugghe
Journal:  Biotechniques       Date:  2001-01       Impact factor: 1.993

2.  Enhancement of p53-dependent gene activation by the transcriptional coactivator Zac1.

Authors:  S M Huang; A H Schönthal; M R Stallcup
Journal:  Oncogene       Date:  2001-04-19       Impact factor: 9.867

3.  A role for E2F1 in Ras activation of p21(WAF1/CIP1) transcription.

Authors:  A L Gartel; F Najmabadi; E Goufman; A L Tyner
Journal:  Oncogene       Date:  2000-02-17       Impact factor: 9.867

4.  WAF1, a potential mediator of p53 tumor suppression.

Authors:  W S el-Deiry; T Tokino; V E Velculescu; D B Levy; R Parsons; J M Trent; D Lin; W E Mercer; K W Kinzler; B Vogelstein
Journal:  Cell       Date:  1993-11-19       Impact factor: 41.582

5.  Cooperation of Sp1 and p300 in the induction of the CDK inhibitor p21WAF1/CIP1 during NGF-mediated neuronal differentiation.

Authors:  N Billon; D Carlisi; M B Datto; L A van Grunsven; A Watt; X F Wang; B B Rudkin
Journal:  Oncogene       Date:  1999-05-06       Impact factor: 9.867

6.  p21(WAF1) is component of a positive feedback loop that maintains the p53 transcriptional program.

Authors:  Lisa Y Pang; Mary Scott; Richard L Hayward; Hisham Mohammed; C Bruce A Whitelaw; Graeme C M Smith; Ted R Hupp
Journal:  Cell Cycle       Date:  2011-03-15       Impact factor: 4.534

Review 7.  MDM2--master regulator of the p53 tumor suppressor protein.

Authors:  J Momand; H H Wu; G Dasgupta
Journal:  Gene       Date:  2000-01-25       Impact factor: 3.688

8.  Two isoforms of otubain 1 regulate T cell anergy via GRAIL.

Authors:  Luis Soares; Christine Seroogy; Heidi Skrenta; Niroshana Anandasabapathy; Patricia Lovelace; Chan D Chung; Edgar Engleman; C Garrison Fathman
Journal:  Nat Immunol       Date:  2003-12-07       Impact factor: 25.606

9.  Sustained expression of GRAIL during hematopoiesis results in dysregulated differentiation.

Authors:  Debra A MacKenzie; Christine M Seroogy
Journal:  Acta Haematol       Date:  2009-10-30       Impact factor: 2.195

10.  Naive CD4 t cell proliferation is controlled by mammalian target of rapamycin regulation of GRAIL expression.

Authors:  Jack T Lin; Neil B Lineberry; Michael G Kattah; Leon L Su; Paul J Utz; C Garrison Fathman; Linda Wu
Journal:  J Immunol       Date:  2009-05-15       Impact factor: 5.422

View more
  23 in total

1.  Integrin α5β1 and p53 convergent pathways in the control of anti-apoptotic proteins PEA-15 and survivin in high-grade glioma.

Authors:  G Renner; H Janouskova; F Noulet; V Koenig; E Guerin; S Bär; J Nuesch; F Rechenmacher; S Neubauer; H Kessler; A-F Blandin; L Choulier; N Etienne-Selloum; M Lehmann; I Lelong-Rebel; S Martin; M Dontenwill
Journal:  Cell Death Differ       Date:  2015-10-16       Impact factor: 15.828

2.  Prognostic value of members of NFAT family for pan-cancer and a prediction model based on NFAT2 in bladder cancer.

Authors:  Zhou-Tong Dai; Yuan Xiang; Yundan Wang; Le-Yuan Bao; Jun Wang; Jia-Peng Li; Hui-Min Zhang; Zhongxin Lu; Sreenivasan Ponnambalam; Xing-Hua Liao
Journal:  Aging (Albany NY)       Date:  2021-05-07       Impact factor: 5.682

3.  RNF128 suppresses the malignancy of colorectal cancer cells via inhibition of Wnt/β-catenin signaling.

Authors:  Yue Zhu; Yujie Gan; Renrui Zou; Huanhuan Sha; Ya Lu; Yuan Zhang; Jifeng Feng
Journal:  Am J Transl Res       Date:  2021-12-15       Impact factor: 4.060

4.  Isoforms of RNF128 Regulate the Stability of Mutant P53 in Barrett's Esophageal Cells.

Authors:  Dipankar Ray; Paramita Ray; Daysha Ferrer-Torres; Zhuwen Wang; Derek Nancarrow; Hee-Won Yoon; May San Martinho; Tonaye Hinton; Scott Owens; Dafydd Thomas; Hui Jiang; Theodore S Lawrence; Jules Lin; Kiran Lagisetty; Andrew C Chang; David G Beer
Journal:  Gastroenterology       Date:  2019-11-09       Impact factor: 22.682

Review 5.  Screening for E3-ubiquitin ligase inhibitors: challenges and opportunities.

Authors:  Vivien Landré; Barak Rotblat; Sonia Melino; Francesca Bernassola; Gerry Melino
Journal:  Oncotarget       Date:  2014-09-30

6.  Bioinformatics analysis of the serine and glycine pathway in cancer cells.

Authors:  Alexey Antonov; Massimiliano Agostini; Maria Morello; Marilena Minieri; Gerry Melino; Ivano Amelio
Journal:  Oncotarget       Date:  2014-11-30

7.  The mechanisms of malic enzyme 2 in the tumorigenesis of human gliomas.

Authors:  Chiao-Pei Cheng; Li-Chun Huang; Yung-Lung Chang; Ching-Hsuan Hsieh; Shih-Ming Huang; Dueng-Yuan Hueng
Journal:  Oncotarget       Date:  2016-07-05

8.  Downregulation of RNF128 Predicts Progression and Poor Prognosis in Patients with Urothelial Carcinoma of the Upper Tract and Urinary Bladder.

Authors:  Yi-Ying Lee; Chieh-Tien Wang; Steven Kuan-Hua Huang; Wen-Jeng Wu; Chun-Nung Huang; Ching-Chia Li; Ti-Chun Chan; Peir-In Liang; Chung-Hsi Hsing; Chien-Feng Li
Journal:  J Cancer       Date:  2016-10-25       Impact factor: 4.207

Review 9.  How Does p73 Cause Neuronal Defects?

Authors:  Maria Victoria Niklison-Chirou; Richard Killick; Richard A Knight; Pierluigi Nicotera; Gerry Melino; Massimiliano Agostini
Journal:  Mol Neurobiol       Date:  2015-08-13       Impact factor: 5.590

10.  Characterization of a new mouse p53 variant: loss-of-function and gain-of-function.

Authors:  James Yi-Hsin Chan; Ying-Chuan Chen; Shu-Ting Liu; Wei-Yuan Chou; Ching-Liang Ho; Shih-Ming Huang
Journal:  J Biomed Sci       Date:  2014-05-08       Impact factor: 8.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.